4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
US8524751B2 · kind B2 · utility
3Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2010 |
| Grant date | Sep 3, 2013 |
| Priority date | — |
| Expiry date | Mar 10, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I):and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.